Clinical Trials Logo

Clinical Trial Summary

The Pilot study will be a single-center, randomized, open-label, active-controlled trial. After CABG surgery using Radial Artery Grafts (RA-CABG) and signing the informed consent, all patients will be screened according to the inclusion and exclusion criteria. Estimated 150 patients will be enrolled and randomized by ratio 1:1:1 to receive either Nicorandil (5mg tid po) or Diltiazem (180mg qd po) or Isosorbide Mononitrate (50mg qd po). Follow-up visits will be conducted at Week 1, 4, 12, and 24 after surgery. The last evaluation of study endpoints and other adverse events will be at Week 24. The pilot study is designed to explore the angiography outcomes of grafts and cardiovascular outcomes of patients, as well as safety outcomes among different anti-spastic regimens after RA-CABG.


Clinical Trial Description

After having signed informed consent (Day 1-3), eligible subjects who have successfully received first RA-CABG surgery (Day 0) will be screened for enrollment. All subjects (150 patients) will be randomized in a 1:1:1 ratio into 3 groups. Group A will receive oral Nicorandil (5mg tid) monotherapy; Group B will receive oral Diltiazem (180mg qd) monotherapy; and Group C will receive Isosorbide Mononitrate (50mg qd) monotherapy. Three groups will continue intervention treatment for 24 weeks after RA-CABG surgery. All subjects will receive follow-up visits (clinic visit or phone visit) at Week 1, 4, 12, and 24 after surgery. All subjects will receive first CCTA (or CAG) to evaluate the graft outcome at Week 1 and second CCTA (or CAG) to evaluate the graft outcome at Week 24 after RA-CABG surgery. And all subjects will be evaluated angina relief based on the Canadian Cardiovascular Society (CCS) angina grading and the Seattle Angina Questionnaire. And the time to first major adverse cardiovascular event (MACE), which include all-cause mortality, myocardial infarction, stroke and unplanned revascularization, will be collected. And other safety outcomes will be evaluated, including the rate of hypotension, the proportion of concomitant medications with ACEI/ARB/ARNI drugs and proportion of SAEs and concerned AEs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04310995
Study type Interventional
Source Ruijin Hospital
Contact
Status Completed
Phase Phase 4
Start date June 2, 2020
Completion date June 28, 2023

See also
  Status Clinical Trial Phase
Completed NCT01688648 - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft N/A
Completed NCT01596738 - Tranexamic Acid in On-pump CABG With Premature Clopidogrel Cessation N/A
Completed NCT00965471 - Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease N/A
Completed NCT05058222 - Effect of Deep Breathing Exercises on Post Operative Sleep Duration N/A
Completed NCT03299101 - Pilot Testing a Home-Based Rehabilitation Intervention Designed to Improve Outcomes of Frail Veterans Following Cardiothoracic Surgery N/A
Completed NCT01535222 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery Phase 2
Completed NCT00863044 - High Frequency Ventilation During Off Pump Coronary Artery Bypass Graft (CABG) Phase 4
Completed NCT01932008 - Evaluation of the Bone Mineral Density and Muscle Mass in Patients Post Coronary Artery Bypass Graft Surgery With Chronic Kidney Disease N/A
Completed NCT05349773 - The Pneumatic Tourniquet Technique for Endoscopic Radial Artery Harvest; Does it Affect Patient Hemodynamics?
Completed NCT03424382 - CREATION Health Readmission Risk Assessment Tool
Not yet recruiting NCT05706545 - Micro- and Macro-Circulation in Cardiac Surgery Patients
Completed NCT01572454 - Comparison of Dexmedetomidine and Remifentanil Infusion During CABG N/A
Completed NCT04993976 - Prehabilitation and Coronary Artery Bypass Grafting N/A
Recruiting NCT01629030 - Risk Factors of Sternal Wound Infection After Coronary Artery Bypass Graft N/A
Completed NCT03925493 - Exercise Prescription in Cardiac Rehabilitation N/A
Not yet recruiting NCT04485143 - Cloud-based ECG Monitoring and Healthcare Model Building on the Population With Coronary Artery Revascularization
Recruiting NCT04231461 - Quality of Life After Cardiac Surgery
Completed NCT03002129 - FLuid Responsiveness Prediction Using EXtra Systoles N/A
Completed NCT01591642 - Physical Activity, Functional Fitness and Quality of Life After Coronary Artery Bypass Grafting N/A
Completed NCT00048308 - Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass Phase 3